跳至主要内容
临床试验/ACTRN12621000606886
ACTRN12621000606886招募中未知

PharmacoKinetic modelling for Antimicrobials in Paediatric Patients on Extracorporeal Therapies (APET)

Queesland Children's Hospital0 个研究点目标入组 140 人开始时间: 2021年5月20日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
o limit 至 18 Years(—)
性别
All

入选标准

  • Patient will be recruited if they meet the inclusion criteria.
  • INCLUSION CRITERIA
  • Paediatrics from birth up to 18 years of age admitted to Paediatric Intensive Care Unit at the Queensland Children’s Hospital and the University Children's Hospital Zurich are eligible if ALL of the following criteria are met.
  • 1. Consent to continue approach (consent will be sought with a followup of written or phone consent to be obtained from the parent or carer, within 24 hours of inclusion in the study.
  • 2. Paediatric patients requiring extracorporeal therapies either extracorporeal membrane oxygenation and/or continuous renal replacement therapy.
  • 3. Patients are prescribed one or more of the following antimicrobials: cefotaxime, meropenem, ampicillin, piperacillin/tazobactam, vancomycin, gentamicin, flucloxacillin, fluconazole, voriconazole, fluconazole, micafungin, anidulafungin, ceftazidime and teicoplanin.
  • 4. Patients may receive multiple antimicrobials concurrently.
  • 5. indwelling catheter

排除标准

  • Patient will not be included if they meet the exclusion criteria
  • EXCLUSION CRITERIA
  • Patients are excluded from the study if ONE OR MORE of the following criteria are met:
  • 1. No consent to continue
  • 2. Known allergy to study antimicrobial
  • 3. Pregnancy
  • 4. Ongoing massive blood transfusion requirements (>50% blood volume transfused in the previous 8 hours) 5. Haemoglobin is less than 70 g/L
  • 6. Therapeutic plasma exchange in the preceding 24 hours
  • 7. No arterial or venous access for sampling

研究者

发起方
Queesland Children's Hospital

相似试验

招募中
不适用
Analgesic, Sedative and Antibiotic Pharmacokinetics during Extracorporeal Membrane Oxygenation: Understanding altered pharmacokinetics to improve patient outcomes.Alterations to the pharmacokinetics of sedative and analgesic drugs and their metabolites (morphine - morphine 3 glucorunide, morphine 6 glucuronide, midazolam - 1 and 4 hydroxy midazolam, fentanyl - norfentanyl, dexmedetiomedine, propofol, thiopentone) in critically ill patients receiving ECMO.Alterations to the pharmacokinetics of broad spectrum antibiotics (ceftriaxone, cefepime, meropenem, gentamicin, ciprofloxacin, ticarcillin-clavulanate, piperacillin-tazobactum, vancomycin, linezolid, caspofungin, fluconazole, voriconazole, oseltamivir/oseltamivir carboxylate) in critically ill patients receiving ECMO.Cardiovascular - Other cardiovascular diseasesRespiratory - Other respiratory disorders / diseasesAnaesthesiology - Anaesthetics
ACTRN12612000559819Critical Care Research Group160
招募中
1 期
Investigating How Anti-Infection Drugs Are Processed in the Bodies of Healthy People and Severely Burned Patients in the Intensive Care Unit
2024-517260-39-00Medical University Of Vienna82
已完成
不适用
Pharmacokinetics of selected antiinfectives during extracorporeal membrane oxygenation (ECMO)J96.0Acute respiratory failure
DRKS00010765niversitätsklinikum Hamburg-EppendorfKlinik für Intensivmedizin44
已完成
不适用
Measuring the antibiotic levels in people with cystic fibrosis taking treatment for mycobacterial lung infection.cystic fibrosis
ACTRN12619000948190niversity of Queensland20
招募中
不适用
Antibiotic disposition in children undergoing heart surgerychildren with heart diseaseCardiac surgery related infectionInfection - Studies of infection and infectious agentsCardiovascular - Other cardiovascular diseasesSurgery - Other surgery
ACTRN12615000809538Brian Anderson50
PharmacoKinetic modelling for Antibiotics and... | 临床试验